Security key
90466Y103
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)
CUSIP: 90466Y103
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 46,786,564
- Total 13F value
- $19,084,180
- Share change
- +27,769,321
- SEC-reported price per share
- $0.41
- Number of holders
- 28
- Value change
- +$10,632,565
- Number of buys
- 21
- Number of sells
- 7
- Shares outstanding
- 18,578,488
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
28
Top holders
10
UNCY full security history
Ownership snapshot
Full 13F holder table
Unicycive Therapeutics, Inc. SEC filings
Unicycive Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital, LLC
Disclosed value leader
Vivo Capital, LLC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 19%
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital, LLC leads the comparable SEC ownership view at 19%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Vivo Capital, LLC
19%
Logos Global Management LP
19%
Nantahala Capital Management, LLC
15%
RA CAPITAL MANAGEMENT, L.P.
14%
BVF INC/IL
12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
Company
|
19%
|
$1,738,893
3,470,152 shares
|
— | 30 Jun 2024 |
| Logos Global Management LP |
13F
Company
|
19%
|
$1,738,780
3,469,927 shares
|
— | 30 Jun 2024 |
| Nantahala Capital Management, LLC |
13F
Company
|
15%
|
$1,413,282
2,820,358 shares
|
— | 30 Jun 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
14%
|
$1,318,995
2,632,200 shares
|
— | 30 Jun 2024 |
| BVF INC/IL |
13F
Company
|
12%
|
$1,102,420
2,200,000 shares
|
— | 30 Jun 2024 |
| Rosalind Advisors, Inc. |
13F
Company
|
8.5%
|
$787,328
1,571,200 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
28
Shares
46,786,564
Rows available
28
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
23
Q3 2024 holders
28
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|